First-time mothers with postpartum mental disorders (PPMD) are predisposed to self-harm, although the risk is lower than that seen among other psychiatric patients, a study reports. Moreover, new moms with severe PPMD who have a history of self-harm make up a vulnerable group at high risk of later suicide.
Consuming high amounts of fish and/or n-3 polyunsaturated fatty acids (PUFAs) is beneficial to women, as it reduces the risk of postpartum depression at 6 months following delivery, according to a recent study.
Women who show symptoms of postpartum depression in the first or sixth month after delivery tend to encounter difficulty caring for their infants, a recent study suggests. Left untreated, the mood disorder can prevent the formation of a critical bond between mother and child.
New drug applications approved by US FDA as of 16 - 31 March 2019 which includes New Molecular Entities (NMEs) and new biologics. It
does not include Tentative Approvals. Supplemental approvals may have
occurred since the original approval date.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Psychiatry - Malaysia digital copy today!
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.